Stay updated on Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    - Added a government funding notice and open status information for the NIH Clinical Center, and a link to operating status timelines. - Updated software revision to v3.2.0. - Removed the resource topic: Carcinoma of esophagus from Genetic and Rare Diseases Information Center.
    Difference
    3%
    Check dated 2025-10-06T04:28:46.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T01:10:03.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed. No substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-14T18:43:21.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-07T13:09:52.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to include specific facility names and locations, as well as new resources related to genetic and rare diseases, particularly focusing on esophageal carcinoma and associated treatments. Notably, the revision number has changed, indicating a significant update.
    Difference
    11%
    Check dated 2025-08-31T05:44:42.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.2%
    Check dated 2025-08-24T03:11:28.000Z thumbnail image

Stay in the know with updates to Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page.